Dialy health newspaper
The EU (European Union) Pharmaceutical group had their yearly symposium taking place in Berlin. This was headed as: 'New Opportunities in Primary Care: Maximising Pharmacist Contributions through Interdisciplinary Collaboration'.
The second form of diabetes (type 2) is an ailment that affects many wealthy members of society, often condemning them to an early grave. Sanofi-Aventis, a pharmaceutical firm is of the opinion that the general public could assist in the implementation of an effective answer to this problem.
In the month of May during the year two thousand and one, a scientist aged only thirty three by the name of Frederick Van Goor turned up at a biotech firm that had recently been purchased by a rival firm, for his first day of work. Upon his arrival, Goors new boss proceeded to inquire of him whether or not he held any information about the genetic factors that lead to the development of cystic fibrosis, an extremely fatal lung disease.
The rate at which diabetes is increasing in status aboriginal adults within Alberta is decreasing in relation with the rate of the population at large; it is nonetheless more common for status aboriginals to suffer from diabetes thus the death rate for status aboriginals is significantly higher than that of the population at large.
A new enzyme has been found by scientists from Ruhr University in Bochum, this enzyme provides new insight into the importation of specified cell based organelles commonly referred to as peroxisomes. The findings from this research were published in the Journal of Biological Chemistry. The research team that discovered these findings was headed by professor Erdmann of the Department of Systematic Biochemistry.
The website http://www.multidose.org now has a novel ASHP toolkit and resource centre. This is able to provide guidelines on the implementation of a MMMD (Multidose Medication Dispensing for Discharge) service. This was made by an experienced group of professional experts and pharmaceutical company managers.